Company Profile For Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd. (Taro) is a multinational, science-based pharmaceutical company that develops, manufactures and markets prescription and over-the-counter (OTC) pharmaceutical products primarily in the United States, Canada and Israel. It also develops and manufactures active pharmaceutical ingredients (APIs) primarily for use in its finished dosage form products. Its primary areas of focus include topical creams and ointments, liquids, capsules and tablets, mainly in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The Company operates through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries: Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets more than 180 pharmaceutical products in over 20 countries. Taro’s product groups include Amiodarone Hydrochloride, Ammonium Lactate, Carbamazepine and Clobetasol Propionate.

BRIEF: For the six months ended 30 June 2009, Taro Pharmaceutical Industries Ltd.'s revenues increased 9% to $181.7M. Net income increased 15% to $23.6M.Revenues reflect an increase in demand for the Company's products and services. Net income also reflects improved gross profit margin and a decrease in interest expenses. The Company develops, manufactures and markets generic pharmaceutical products.

Taro Pharmaceutical Industries Ltd.
c/o Taro U.S.A. Inc.
Five Skyline Drive
Hawthorne   NY   10532
P: +1914.3459001
F: +1914.3458728

1149